thymoma
thymoma
Explore linked clinical trials. Standard reference: MONDO:000645639 results ยท Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma | Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenoma, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, gastric neoplasm, gonadal disorder, intestinal disorder, lung disorder, lung neoplasm, lymphatic system disorder, malignant endocrine neoplasm, mesothelial neoplasm, mesothelioma, mixed neoplasm, neoplasm, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic neoplasm, respiratory system disorder, respiratory tract neoplasm, stomach disorder, thymoma | Recruiting | Phase 1 | 2026-10-06 | NCT06885697 | |
| A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, autosomal dominant Parkinson disease 4, lymphatic system disorder, mixed neoplasm, neoplasm, thymoma | Active, not recruiting | Phase 2 | 2026-10-02 | NCT03076554 | |
| Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma | Adnexal Diseases, Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenoma, biliary tract disorder, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, gastric neoplasm, gonadal disorder, lung disorder, lung neoplasm, lymphatic system disorder, malignant endocrine neoplasm, mesothelial neoplasm, mesothelioma, mixed neoplasm, neoplasm, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic neoplasm, respiratory system disorder, respiratory tract neoplasm, stomach disorder, thymoma | Recruiting | Not stated | 2026-10-02 | NCT01950572 | |
| Incidence and Predictors of Early Clinical Relapse Within Six Months After Thymectomy in Patients With Myasthenia Gravis | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Thoracic Neoplasms, Thymus Neoplasms, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, lymphatic system disorder, mixed neoplasm, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome, thymoma | Not yet recruiting | Not stated | 2026-10-01 | NCT07853378 | |
| An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, thymoma | Active, not recruiting | Not applicable | 2026-09-18 | NCT03968315 | |
| HEARTS Trial for Thoracic Cancers | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, bronchial neoplasm, bronchogenic carcinoma, digestive system disorder, digestive system neoplasm, esophageal disorder, lung disorder, lung neoplasm, lymphatic system disorder, mixed neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, thymoma | Recruiting | Phase 2 | 2026-09-15 | NCT07132918 | |
| SP Thoracic IDE Study | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, Thoracic Neoplasms, Thymus Neoplasms, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, lymphatic system disorder, mixed neoplasm, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome, thymoma | Active, not recruiting | Not applicable | 2026-09-14 | NCT05150210 | |
| A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, thymoma | Recruiting | Phase 2 | 2026-09-11 | NCT06248515 | |
| PT-112 in Subjects With Thymoma and Thymic Carcinoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, thymic epithelial neoplasm, thymoma, thymus cancer | Recruiting | Phase 2 | 2026-08-28 | NCT05104736 | |
| Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, thymic epithelial neoplasm, thymoma, thymus cancer | Active, not recruiting | Phase 2 | 2026-08-28 | NCT04417660 | |
| Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, thymoma | Recruiting | Phase 2 | 2026-08-12 | NCT07324629 | |
| A Phase II, Investigator-Initiated Exploratory Study of Sacituzumab Tirumotecan for Previously Treated Unresectable Thymic Carcinomas | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, thymoma | Not yet recruiting | Phase 2 | 2026-08-06 | NCT07750353 | |
| Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, thymoma | Active, not recruiting | Phase 2 | 2026-08-06 | NCT03463460 | |
| Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, thymoma | Active, not recruiting | Phase 2 | 2026-07-29 | NCT01025089 | |
| Hypofractionated Adjuvant Radiotherapy for Thymic Epithelial Tumors | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, thymic epithelial neoplasm, thymoma | Not yet recruiting | Not applicable | 2026-07-16 | NCT07693855 | |
| Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, thymoma | Recruiting | Phase 1 | 2026-07-16 | NCT03295227 | |
| IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers | Female Urogenital Diseases and Pregnancy Complications, Gestational Trophoblastic Disease, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pregnancy Complications, Neoplastic, Thoracic Neoplasms, Thymus Neoplasms, Urogenital Diseases, adenocarcinoma, carcinoid tumor, carcinoma, digestive system neuroendocrine neoplasm, epithelial neoplasm, gestational trophoblastic neoplasm, lymphatic system disorder, mixed neoplasm, neoplasm, neuroendocrine neoplasm, peritoneal mesothelioma, pregnancy disorder, primitive neuroectodermal tumor, thymoma, thyroid gland undifferentiated (anaplastic) carcinoma, trophoblastic neoplasm | Active, not recruiting | Phase 2 | 2026-06-25 | NCT06790706 | |
| Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, thymic epithelial neoplasm, thymoma | Recruiting | Phase 1 / Phase 2 | 2026-05-20 | NCT07598955 | |
| Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM) | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, thymoma, thymoma type B3 | Active, not recruiting | Phase 2 | 2026-05-15 | NCT03134118 | |
| Neoadjuvant Treatment For Locally Advanced Thymic Cancer | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, thymoma | Recruiting | Phase 2 | 2026-05-08 | NCT06019468 | |
| Thymic Disease, Autoimmunity, and Neuromuscular Junction Integrity in Myasthenia Gravis | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, Thoracic Neoplasms, Thymus Neoplasms, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, lymphatic system disorder, mixed neoplasm, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome, thymoma | Not yet recruiting | Not stated | 2026-05-06 | NCT07571525 | |
| Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3) | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, thymoma | Recruiting | Phase 3 | 2026-04-27 | NCT06402708 | |
| Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, thymoma | Recruiting | Not applicable | 2026-04-24 | NCT02633553 | |
| Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mixed neoplasm, neoplasm, thymoma | Not yet recruiting | Phase 2 | 2026-03-18 | NCT07479628 | |
| 6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors | Hemic and Lymphatic Diseases, Mediastinal Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Diseases, Thoracic Neoplasms, Thymus Neoplasms, lymphatic system disorder, mediastinal cancer, mixed neoplasm, neoplasm, respiratory system disorder, thymic epithelial neoplasm, thymoma | Not yet recruiting | Phase 2 / Phase 3 | 2026-03-11 | NCT07463313 |